medigraphic.com
ISSN 0016-3813 (Print)

2004, Number 3

<< Back Next >>

Gac Med Mex 2004; 140 (3)

Hospital Mortality at the Manuel Velasco Suárez National Institute of Neurology and Neurosurgery (1995-2001).

Velásquez-Pérez L, Jiménez-Marcial ME

Language: Spanish
References: 25
Page: 289-294
PDF size: 49.70 Kb.


ABSTRACT

To improve health policies directed toward ameliorating quality and also to characterize the profile of patients who attend medical centers, it is necessary to determine causes of mortality in any healthcare organization. Objective: To analyze time-trend hospital mortality at the Manuel Velasco Suárez National Institute of Neurology and Neurosurgery (MVS-NINN) between 1995 and 2001. Methods: Data were taken from database of morbidity and mortality of MVS-NINN. All cases were coded by the International Classification of Disease (10th edition). We calculated specific rates of mortality and time-trends during a 7-year-period. Results: When main causes of mortality were included in these analyzes, rates of hospital mortality at MVS-NINN showed a non-significant tendency to decrease during this period. Conclusions: Decline of mortality time-trend is generally in accordance with increasing life expectancy of Mexican population; this increase is due to progress in medical knowledge and to new technological and therapeutic advances, especially in the third level institutions such as this institute.


REFERENCES

  1. Jiménez-Ornelas RA. La desigualdad de la mortalidad para la República Mexicana y sus entidades federativas 1990. Cuernavaca, Mor.: Centro Regional de Investigaciones Multidisciplinarias-Universidad Nacional Autónoma de México, 1995:9-11.

  2. Vandale S, Rascón-Pacheco RA, Kageyama ML. Time trends and causes on infant neonatal and posneonatal mortality in Mexico 1980-1990. Salud Publica Mex 1997;39:48-52.

  3. López RO. Efecto de los Servicios de Salud y de factores socioeconómicos en las diferencias espaciales de la mortalidad mexicana Salud Publica Mex 1997;39:16-24.

  4. Chackie J. La mortalidad en América Latina: niveles, tendencias y determinantes. En: Memorias del congreso Latinoamericano de población y Desarrollo. México D.F.: UNAM, El Colegio de México, PISPAL, 1984; vol. 1:157-186.

  5. Fondo de las Naciones Unidas para la Infancia. Estado Mundial de la infancia. Nueva York: UNICEF,1998.

  6. Aspectos relevantes sobre la estadística de egresos hospitalarios del Sistema Nacional de Salud. www.insp.mx/salud/39/392-11s.html

  7. Batista MR, Landrove RO, Bonet GM, et al. Sistema de Vigilancia de enfermedades no transmisibles en Cuba. Rev Cubana Hig Epidemiol 2000;38:77-92.

  8. Rashand H, Gray R, Boerma T. From Clinical trials to large scale applications of Health interventions: facts and issues of concern. En: Rashad H, Gray R, Boerma T. ed. Evaluation of the impact of health interventions. Belgica: international Union for Scientific Study of Population, 1995:11-10.

  9. Benavide FG, Bolumar F, Peris R. Quality of death certificates and its effect on cancer mortality statistics. Am J Public Health 1989;79:1352-1354.

  10. López-Abente OG, Pollan M, Escolar PA, et al. Atlas de Mortalidad por Cáncer y Otras Causas España 1975- 1986. Instituto de salud Carlos III. Ministerio de sanidad y Consumo. Centro Nacional de epidemiología. Servicio de Epidemiología del Cáncer Madrid. Publ. No. 0466, Lyon 1992.

  11. Organización Panamericana de la salud. Clasificación Estadística Internacional de Enfermedades y Problemas Relacionados con la Salud. Décima versión, Washington DC:OPS, 1995.

  12. Dawson-Saunders B, Trapp RG. Correlación y Regresión. En: Dawson-Saunders B, Trapp RG, editores. Bioestadística Médica. México D.F. Editorial El Manual Moderno S.A de C.V; 1993 pp. 187-214.

  13. Ahlbom A. The P-Value, The P-Value Function and the Confidence Interval. En: Ahlbom A. Biostatistics for Epidemiologists. Lewis Publishers:1991 pp.35-54.

  14. Aicking M, Dunn CN, Flood TJ. Estimation of population denominators for public health studies at the tract, gender, and age-specific level. Am J public Health 1991;81:918-920.

  15. Stata Corporation. Stata 5.0. Colege Station, TX: Stata Corporation, 1997.

  16. Arriaga E. Changing trends in mortality decline during the last decades. En: Ruzicka L, Wunsch G, Kane P, ed. Differential mortality, methodological issues and biosocial factors. Londres: Claerendon Press Oxford, 1985:105-129.

  17. National Center for Health Statistics. Health, United States, 1990. Hyattssville: Public Health Service, 1991.

  18. Garland FC, Lilienfeld AM, Garland CF. Decline trends in mortality from cerebrovascular disease at age 10-65 years: a test of validity.Neuroepidemiology 1989;8:1-23.

  19. Flag MJ, Whelton PK, Seidler AJ. Decline in U.S. stroke mortality. Stroke 1989;20:14-21.

  20. Murray CJL, López AD. Mortality by cause for eight regions of the world: Global Burden Of Disease Study. Lancet 1997;349:1269-1276.

  21. Qureshi AI, Safdar K, Patel M, Jansen RS, Frankel MR. Stroke in young black patients: risk factors, subtypes androprognosis. Stroke 1995;26:1995-1998.

  22. Lacerda GA, Abreu PD, Borroto PR, Betancourt EJ. Mortalidad por Hemorragias intracerebrales espontáneas. Estudio clinicopatológico. Rev Cubana Cir 2000;39:97-102.

  23. Bonita R, Veaglehole R, Asplund K. The worldwide problem of stroke. Curr Opin Neurol 1994;7:5-10.

  24. Sacco RL, Benjamin EJ, Broderick JP, et al. Risk factors panel-American Heart Association Prevention Conference IV. Stroke 1997;28:1507-1517.

  25. Izazola LJA, Valdez GM, Sánchez PH, Del Río CHC. La Mortalidad por el SIDA en México de 1983 a 1992. Tendencias y años perdidos de vida potencial. Salud Pública de Méx 1995;37:140-148.




2020     |     www.medigraphic.com